LATEST ALERTS
Tamarind Intelligence data continues to be an invaluable tool used by governments and NGOs around the world, contributing to a wide number of government and supra-national projects
This report provides a detailed overview of the current regulatory framework in place in Portugal for hemp, cannabis and other cannabinoids, covering all policy areas
This report seeks to outline the labelling and packaging requirements that cannabis-containing medicinal products need to comply with when their placing on the European market is authorised
Cold-pressed hemp oils appear to provide a way for CBD producers to circumvent UK rules on novel foods – but while some are all in favour, others see dangers and shortcomings
The US Drug Enforcement Administration (DEA) has clarified its position on two synthetic hemp derivatives, confirming that it considers delta-8 THCO and delta-9 THCO illegal
Twitter’s recently announced “change” in the social media platform’s policy to allow cannabis advertisements in the US is full of sound but signifies nothing
Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US
This comprehensive CBD markets database is a one-stop source for market sizes, forecasts and product-specific analyses, covering Austria, Canada, France, Germany, Greece, Ireland, Italy, Japan, Netherlands, Spain, Switzerland, the UK and the US
Mexican CBD shop Paradise says it has placed itself in prime position for the creation of a legal recreational cannabis market in the country
This report provides a detailed overview of the current regulatory framework in place for CBD and other cannabinoids, hemp and cannabis
The European Food Safety Authority denies it is waiting research results on the safety of CBD by the US Food and Drug Administration before it lets validated candidates complete the novel food application process
US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
This interactive dashboard provides a detailed look at the current CBD market in Japan, including information about product formats, pricing and brands
This interactive dashboard provides a detailed look at the current CBD market in the Netherlands, including information about product formats, pricing and brands
This interactive dashboard provides a detailed look at the current CBD market in the United States, including information about product formats, pricing and brands
This interactive dashboard provides a detailed look at the current CBD market in France, including information about product formats, pricing and brands
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
This interactive dashboard provides a detailed look at the current CBD market in the UK, including information about product formats, pricing and brands
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Notifications
